284 related articles for article (PubMed ID: 10483993)
1. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
6. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
7. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
Kullich W; Pöllmann G; Czerwenka C; Klein G
Wien Med Wochenschr; 1999; 149(7):157-61. PubMed ID: 10413837
[TBL] [Abstract][Full Text] [Related]
8. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
9. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
[TBL] [Abstract][Full Text] [Related]
11. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections.
Nurgalieva ZZ; Opekun AR; Graham DY
Helicobacter; 2006 Apr; 11(2):69-74. PubMed ID: 16579835
[TBL] [Abstract][Full Text] [Related]
12. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
13. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
14. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Gong Y; Wei W; Yuan Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
[TBL] [Abstract][Full Text] [Related]
15. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
Daugule I; Ruskule A; Moisejevs G; Rudzite D; Jonaitis L; Janciauskas D; Kiudelis G; Kupcinskas L; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
[TBL] [Abstract][Full Text] [Related]
17. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis.
Irvani S; Hashemi MR; Moghadam KG; Saeidee S; Khavaran K; Najari O; Ranavardi M; Nasiri S; Salmasian H; Rohanizadegan M
Minerva Gastroenterol Dietol; 2010 Mar; 56(1):13-7. PubMed ID: 20190719
[TBL] [Abstract][Full Text] [Related]
19. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
20. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
